Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$6,173,076
-$1,358,232 QoQ
Shares Held
256,357
-4.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#536
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026First Fiduciary Investment Counsel, Inc. holds $51,339,791 across 7 Drug Manufacturers - General names. PFE ranks #4 (12.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
73,221 | $18,595,937 | |
| 2 | NVS |
Novartis AG
|
99,224 | $15,550,385 | |
| 3 | AMGN |
Amgen Inc
|
25,171 | $9,114,922 | |
| 4 | PFE |
Pfizer Inc
This page
|
256,357 | $6,173,076 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,118 | $914,663 | |
| 6 | LLY |
ELI LILLY & Co
|
435 | $521,752 | |
| 7 | ABBV |
AbbVie Inc.
|
1,864 | $469,056 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,173,076 | 256,357 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $7,531,308 | 268,209 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $6,807,585 | 273,397 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $5,904,531 | 231,732 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $5,745,922 | 237,043 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $5,881,794 | 232,115 | Shares | Sole | 2025-04-25 | |
| 2024-12-31 | $5,076,037 | 191,332 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $6,800,957 | 235,002 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $7,007,339 | 250,441 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $6,993,305 | 252,011 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $7,355,758 | 255,497 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $8,817,249 | 265,820 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $9,520,954 | 259,568 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $8,884,281 | 217,752 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $10,494,310 | 204,807 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $9,084,751 | 207,604 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $10,955,300 | 208,951 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $10,977,828 | 212,050 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $25,476,059 | 431,432 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $19,774,234 | 459,759 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $19,149,866 | 489,016 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $19,312,329 | 533,048 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $20,698,520 | 562,307 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $20,817,283 | 567,229 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $18,824,690 | 575,678 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $18,755,506 | 574,618 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||